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Open acca b s t r a c t
Exces s production of superoxide (O2) and nitric oxide (NO) in blood vessel walls may occur early in
atherogenes is leading to the formation of peroxynitrite, a strong oxidant and nitrating agent. This 
study was designed to determine the effect of dipheny l diseleni de (PhSe)2, a synthetic organoselenium 
comp ound, in comparison with ebselen, on peroxynitrite-mediated endothelial damage. Experimental 
results showed that pre-incu bation of BAEC (24 h) with low concentrations of (PhSe)2 (0.5 and 1 lM)
protected the cells from peroxynitrite-dependent apoptosis and protein tyrosine nitration. The intra- 
cellular levels of GSH were almost comp letely depleted by peroxynitrite and, although the compounds 
did not restore its normal levels, (PhSe)2 per se signiﬁcantly increased GSH in a concentration- 
depende nt manner. Moreover, (PhSe)2, which was about two times more active as a GPx mimic than 
ebselen, induced a signiﬁcantly higher increase in both cellular GPx expression and activity. Taking 
into account the kinetics of the reaction between peroxynitrite and (PhSe)2, our data indicate that 
(PhSe)2 protects BAEC against peroxynitrite-mediated cell dama ge not by a direct reaction, but rather 
by increasing cellular GPx expression as a consequence of enhanced nuclear translocat ion of Nrf-2,
which together with the increase in intracellular GSH, may work catalytically to reduce peroxynitrite 
to nitrite.
 2013 Published by Elsevier Inc. Open access under the Elsevier OA license. Introductio n
Atheroscleros is and subsequent vascular diseases are the main 
cause of morbidity and mortality in the developed world. Vascu- 
lar oxidative injury and LDL oxidation in the intima of arteries 
have been recognized as important steps in atheroge nesis, lead- 
ing to endotheli al cell dysfunction [1,2]. Actually, it has been re- 
ported that an overproduc tion of reactive oxygen and nitrogen 
species in the vascular endothelium occurs very early in the 
atherogenic process, suggesting a link between reactive oxidant C, bovine aortic endothelial 
peroxidase; GR, glutathione 
e.
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ess under the Elsevier OA license. species, LDL oxidation, and endotheli al cells dysfunction and 
apoptosis [3,4].
Peroxynitr ite,1 a biologicall y relevant oxidizing and nitrating 
agent, is formed from the diffusion-con trolled reaction between ni- 
tric oxide (NO) and superoxide (O2). Of particular importan ce, per- 
oxynitri te is a powerful reactive and short-liv ed species that can 
promo te oxidative damage to most classes of biomolec ules [5–7].
In addition to the generati on of pro-oxid ant species, the formation 
of peroxynit rite results in decreased bioavailabilit y of NO, therefore 
diminis hing both its salutary physiologic al functions [8,9] and its 
strong antioxida nt actions over free radical and metal-mediat ed pro- 
cesses [10,11]. The ability of peroxynitrite to oxidize and covalent ly
modify a wide range of biomolecules , includi ng thiols [12], DNA,
protein s and lipids, can affect importan t cellular functions in such 1 The term peroxynitrite is used to refer to the sum of peroxynitrite anion (ONOO)
and peroxynitrous acid (ONOOH), whose IUPAC recommended names are
oxoperoxynitrate (1) and hydrogen oxoperoxynitrate, respectively.
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apoptosis or necrosis may occur [13–15].
The involvement of peroxynitrite in atherosclerosis has been 
suggested either by its ability to oxidize LDL or by the extensive 
nitration of protein tyrosine, detected in human atherosclero tic le- 
sions [16–18]. Therefore, it is important to countera ct peroxyni- 
trite-damagi ng effects. One of the possible strategies is to
intercept this reactive species in order to prevent the damage to
potentially sensitive biological targets [15,19]. Organoselen ium 
compounds may fulﬁll such requiremen ts, as it has been reported 
for ebselen, which efﬁciently reacts with peroxynitrite. In fact, the 
second-order rate constant for this reaction (2.0  106 M1 s1, pH
7.4) is one of the highest for a low-molecu lar-weight compound 
with peroxynitrite, as known so far [20,21]. Some organoselenium 
compounds have been shown to prevent protein oxidation and 
nitration [22,23] and to protect DNA against peroxynitrite- medi- 
ated damage [24]. Additionally, it has been shown that ebselen 
prevents the recruitment of leukocyt es into inﬂamed tissues by
attenuating peroxynitrite- mediated IL-8 gene expression [25].
Moreover, clinical studies have demonstrated that ebselen im- 
proves neurological outcome in patients with acute ischemia,
stroke or subarachno id hemorrhage [26–28], pointing to the po- 
tential therapeutic signiﬁcance of organoselenide s.
Recently, it was demonstrat ed that ebselen protection is accom- 
plished through the nuclear translocation of the transcription fac- 
tor Nrf-2 triggering Nrf-2-depen dent signaling [29–31]. Nrf-2 
binds to the antioxidant responsive elements (ARE) and accelerates 
the transcriptio n of the cognate genes, which can be classiﬁed into 
three separate classes, those that are involved in glutathione syn- 
thesis, detoxiﬁcation enzymes , and those directly involved with 
the amelioration of oxidative stress [32]. Under basal conditions,
Keap1, a protein associated with the actin cytoskeleton, binds very 
tightly to Nrf-2, anchors this transcrip tion factor in the cytoplasm ,
and targets it for ubiquitinati on and proteasome degradation ,
thereby repressing the ability of Nrf-2 to induce phase-2 detoxiﬁ-
cation enzyme genes [33].
Diphenyl diselenide [(PhSe)2], a simple organoselenium com- 
pound, has shown important antioxidant and pharmacolo gical 
properties. In fact, in the presence of a reducing thiol, this com- 
pound reacts very efﬁciently with hydroperox ides and organic per- 
oxides, mimicking the glutathione peroxidase (GPx) enzyme [34].
This GPx-like activity of (PhSe)2 has been reported to be even high- 
er than that of ebselen, displaying also a lower toxicity to mamma- 
lian cells [35,36]. Moreove r, recent data from our group have 
demonstrat ed that (PhSe)2, as ebselen, is a good substrate of hepa- 
tic and cerebral TrxR enzymes , a fact that contributed to its power- 
ful antioxidant action [30,37,38]. Of note, we have recently shown 
that (PhSe)2 protects human platelets against lipoperoxidatio n in- 
duced by sodium nitroprussid e (SNP), by increasing GPx-like activ- 
ity in these cells [39]. Additionally, we showed that oral treatment 
with low doses of (PhSe)2 potently reduced the formatio n of ath- 
erosclerotic lesion in hypercholesterol emic, low-densi ty lipopro- 
tein (LDL) receptor knockout (LDLr/) mice [40] and inhibited 
human LDL oxidation [41], facts that were related to its thiol-per- 
oxidase activity. Of particular importance , (PhSe)2 protected hippo- 
campal slices from glucose–oxygen deprivati on and its 
neuroprotecti ve effect seems to be related to a normalization of
iNOS overexpression induced by ischemia [42].
The aim of this study was to explore whether (PhSe)2 displays a
protective effect against peroxynitrite- mediated toxicity, in pri- 
mary cultures of bovine aortic endothelial cells (BAEC). In addition,
experiments to unveil the mechanics behind the protective effects 
observed with (PhSe)2 were performed. Our data indicates that 
(PhSe)2 is able to partially prevent programmed cell death in BAEC 
triggered by peroxyni trite in a more efﬁcient way than ebselen,
most probably through an Nrf-2-de pendent increase in cellular GSH levels and GPx activity rather than a direct reaction with 
peroxyni trite.Material s and methods 
Materials
General laborator y chemicals and some speciﬁc ones, namely,
collagenas e, gelatin, streptomy cin/penicillin, MTT, Hoechst 
33,258, ethylene diamine tetra acetic acid (EDTA), ortho-phthal- 
deyde, GSH and glutathione reductase were obtained from Sigma 
Chemical s (St. Louis, MO). For cell culture, Dulbecco’s modiﬁed Ea- 
gle’s medium (DMEM), trypsin 0.25%, fungizone, fetal bovine ser- 
um (FBS) and phosphat e-buffered saline (PBS) pH 7.4, were 
purchase d from Gibco-Invi trogen. (PhSe)2 was synthesized as pre- 
viously described [43]. Analysis of the 1H NMR and 13C NMR spec- 
tra showed that the compound obtained presented analytical and 
spectroscopi c data in full agreement with its assigned structure .
The chemical purity of (PhSe)2 (99.9%) was determined by GC/ 
HPLC.Primary cultures of bovine aortic endothelial cells 
Bovine aortic endothelial cells (BAEC) were obtained from tho- 
racic aorta by treatment with collagenase (2 mg/ml). Cells were 
cultivated on gelatin-coated tissue culture plastic in DMEM sup- 
plemente d with 10% fetal bovine serum, 100 U/ml penicillin,
100 lg/ml streptomy cin and 50 lg/ml fungizone at 37 C, in a
humidiﬁed atmosphere of 5% CO2. Endothelial cells were identiﬁed
by their cobblestone morphology and uptake of ﬂuorescently la- 
belled acetylated LDL. Cells were subcultur ed at conﬂuences and 
used between the fourth and the seventh passage. Prior to the 
experime nts, cells at 80% of conﬂuence were starved in serum-free 
medium for 24 h.Peroxynitri te synthesis 
Peroxynitrit e was synthesized by using a quenched ﬂow reac- 
tor, as previousl y described [44] and was stored at 80 C under 
N2 atmosphere . Before use, ONOO  was spectrophotom etrically 
quantiﬁed at 302 nm in 1 N NaOH (e = 1670 M1 cm1).Peroxynitri te exposure 
The exposure of BAEC to peroxynitrite was performed as previ- 
ously described by Brito et al. [45]. In brief, cells were washed and 
equilibrated with potassium phosphate buffer (PBS) containing 
0.9 mM calcium chloride and 0.5 mM magnesium chloride, pH
7.4 for 5 min. Afterwar ds, cells were exposed to peroxynitrite (ﬁnal
concentr ation 500 lM), for 10 min and then they were washed and 
replaced in culture medium for 6 h. The same volumes of either 
10 mM NaOH (vehicle control) or pre-decompos ed ONOO 
(ONOO was decomposed in PBS overnight) were used as controls.
In a parallel set of experiments, BAEC were exposed to three bolus 
of 50 lM peroxynitrite in order to verify peroxynitrite-m ediated 
nitration by determination of 3-nitrotyr osine residues in proteins.
When required, cells were pre-incubat ed with (PhSe)2 or ebselen in
a medium free of fetal bovine serum (FBS) for 24 h. At the end of
the indicated times, the incubation medium was gently removed 
and the cells were incubate d with peroxynitrite as described 
above. In these conditions, the compounds were not present in
the incubation medium throughout the experiment with 
peroxyni trite.
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Cells (0.5  106 cells/well) seeded in 6 well plates were incu- 
bated in a medium free of FBS with various concentrations of
(PhSe)2 or ebselen for 24 h. Cell viability was then assessed by
the MTT test accordin g to Denizot and Lang [46]. Brieﬂy, after 
the incubation period, the medium was removed , the cells were 
washed with PBS and 1 ml of PBS containing 100 ll of MTT (1 g/
L) was added to each well and incubated for 1 h at 37 C. Formaza n
crystals were dissolved in DMSO and the absorbance was read at
530 nm. Results were expressed as a percentage of control cells.Nuclear morphology 
Cells were ﬁxed with freshly prepared 4% (w/v) paraformalde- 
hyde in phosphate buffered saline (PBS, pH 7.4) for 15 min at room 
temperature and subsequently stained with Hoechst dye 33,258 
(5 lg/ml) for 15 min, washed with PBS and mounted by using 
PBS/glycerol (3:1, v/v). Cells were examined by ﬂuorescence
microscopy , with a Nikon epiﬂuorescence microscop e. Stained nu- 
clei were scored according to the condensation and staining char- 
acteristics of chromati n. Apoptotic nuclei were identiﬁed by
condensed chromatin and nuclear fragmentati on and were 
counted in at least ﬁve random microscopic ﬁelds (400) per sam- 
ple. Mean values were expresse d as the percentage of apoptotic 
nuclei.Protein 3-nitrotyrosine determination 
BAEC (0.5  106 cells/well) were pre-treated with the organose- 
lenium compound and then exposed to peroxyni trite according 
previous described . Afterwards, plates were washed with PBS 
and scraped in a lysis buffer (0.05 M Tris, 1.75 mM EDTA, 5% SDS,
pH 6.8). Western blot analysis was performed on total cell extracts.
Proteins (30 lg) were resolved by 12% SDS–PAGE, transferred to
nitrocellulos e membran es and blocked with 3% low fat milk in
50 mM PBS for 1 h. Membranes were then overnight probed at
4 C, with a polyclonal rabbit anti-3-nitrotyr osine antibody (di-
luted 1:1000 in TBS 0.1% wt/vol BSA and 0.6% vol/vol Tween-20)
produced in our laborator y. Immunoreactive proteins were de- 
tected using the Immun-Star Chemiluminescen ce Kit (Bio-Rad)
ECL super signal. A semiquantitati ve determination of nitrated pro- 
teins was performed by densitometri c analysis using the J-Image 
freeware (National Institutes of Health) by measuring the ratio be- 
tween the bands and total protein load per lane as develope d by
Ponceau-S staining of the nitrocellulos e membrane.Measuremen t of cellular reduced glutathio ne
Intracellular levels of GSH were determined by a ﬂuorimetric
assay as previously described [47]. In brief, cells (0.5  106 cells/
well) seeded in 6 well plates, were scrapped with 0.6 M perchlori c
acid and recovered into 100 mM PBS containing 5 mM EDTA, pH
8.0 at 4 C. Samples were centrifuged at 14,000 rpm at 4 C for 
10 min. A volume of 100 ll of supernatant was incubated with 
100 ll of ortho-phthaldehyde (0.1% w/v in methanol) and 1.8 ml
of 100 mM Na2HPO4 for 15 min at room temperature. Fluorescenc e
intensity was read in a Perkin-Elme r LS 50B spectroﬂuorometer at
an emission wavelength of 420 nm with an excitation wavelength 
of 350 nm (slits width 3.5 nm). Cellular GSH content was calcu- 
lated by using concurrently run standard curve. Cellular protein 
content was quantiﬁed by the Bio-Rad protein assay dye, using bo- 
vine serum albumin as the standard.Gamma-g lutamylcysteine synthetase (GGCS) activity 
GGCS activity was assayed as described by Seeling and Meister 
[48] with slight modiﬁcations. BAEC (0.5  106 cells/well) seeded 
in 6 well plates were washed with PBS and scraped in a lysis buffer 
containing 0.1 M Tris–HCl (pH 8), 5 mM MgCl 2, and 0.5% of Triton.
Cells were centrifuged at 12,500 g for 30 min and the supernat ants 
were used for the enzyme activity determination following NADH 
oxidation at 340 nm in a reaction mix containing 0.1 M Tris–HCl
(pH 8), 150 mM KCl, 5 mM Na2–ATP, 2 mM phosphoenol pyruvate,
10 mM L-glutamate, 10 mM L-a-aminobuty rate, 20 mM MgCl 2,
0.2 mM NADH, and 17 lg of pyruvate kinase and lactate dehydro- 
genase. Data were expressed as nmol NADH oxidized/min/mg 
protein.
Measurem ent of glutathio ne peroxidase-l ike activity 
The GPx like activity of (PhSe)2 was evaluated by the method of
Flohé and Gunzler [49]. The assays were performed at 37 C in 2 ml
of medium containing 50 mM PBS, pH 7.0, 1 mM EDTA, 1 mM re- 
duced GSH, 1 U of GR and 0.15 mM NADPH. Increasing concentr a-
tions of (PhSe)2 were added to the mixture and the reaction was 
initiated by addition of H2O2 (0.2 mM ﬁnal concentratio n). The 
reaction was carried out with gentle stirring, for 2 min, and the 
activity was followed by the decrease in NADPH absorption at
340 nm. Appropriate controls were carried out without (PhSe)2
and were subtracted. In parallel, ebselen was used as a reference 
compound with GPx-like activity.
Glutathio ne peroxidase expression 
BAEC (0.5  106 cells/well) seeded in 6 well plates were washed 
with PBS and scraped in a lysis buffer (0.05 M Tris, 1.75 mM, EDTA,
5% SDS, pH 6.8). The cell extracts were homogen ized by sonication 
and then centrifuged at 12,000 g, 4 C for 15 min. The supernatant 
was separated and 0.025 M Tris buffer containing glycerol (66%)
and 9.5 mM b-mercaptoethano l was added, then samples were 
boiled for 5 min. Proteins were resolved by 15% SDS–PAGE, trans- 
ferred to nitrocellul ose membranes and blocked with 3% low fat 
milk in 50 mM PBS for 1 h. Membranes were then probed at 4 C,
overnight with rabbit policlonal anti-glutathione peroxidase 4
(GPx4) antibody (1:1000 dilution), (Abcam). For the detection,
immunoc omplexed membranes were washed in PBS containing 
0.6% Tween 20, and probed with Odyssey Goat anti-rabb it antibody 
at room temperat ure for 1 h (1:10,000 dilution) (Li-COR Biosci- 
ences, Lincoln, NE). After extensive washing, the membran es were 
scanned with the Odyssey Infrared Imaging System (Li-COR Biosci- 
ences; Lincoln, NE) and a semiquan titative densitometri c analysis 
was performed using Odyssey V3.0 software. Results are expresse d
as the ratio between GPx4 and b-actin band intensities . Equal load- 
ing of gel lanes was veriﬁed by probing the blots for b-actin
content.
Kinetics of the reaction of peroxynitrite with diphenyl diselenide and 
its reduced form 
The kinetics of the reaction between peroxynitrite and (PhSe)2
and its reduced form was performed by following their effect on
peroxyni trite decay at 302 nm in an stopped ﬂow spectrophot om- 
eter (SF MV17, Applied Photophysic s) in 50 mM PBS plus 0.1 mM
DPTA, pH 7.4 at 37 C. In the case of the reaction between perox- 
ynitrite and the oxidized form of the (PhSe)2, peroxynitrite was 
rapidly mixed with up to 10 lM of the compound, due to its low 
solubility in aqueous solutions. In the case of the reduced form of
the compound , different (PhSe)2 concentr ations were incubate d
with DTT in excess (1 mM) in 100 mM sodium phosphate 0.2 mM
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apparatus, and then mixed with peroxyni trite in the second syr- 
inge. Control experiments were performed mixing peroxynitrite 
with DTT (1 mM) in the absence of (PhSe)2. Observed rate con- 
stants of peroxynitrite decay in the absence or presence of the indi- 
cated compound s were obtained by ﬁtting experimental traces to
exponential curves with ﬂoating end points. From the plot of ob- 
served rate constants of peroxynitrite decay vs. different reduced 
selenol concentrations , the second order rate constant for the reac- 
tion was determined. Absorbance spectra of (PhSe)2 in the absence 
or presence of excess DTT were registered in a temperature -con- 
trolled Shidmatzu spectrophot ometer.
Nrf-2 nuclear translocation 
Cells (3.0  105 cells/well) seeded in coverslip s in 12 wells plate 
were ﬁxed with 2% paraformaldehy de and blocked with 4% of albu- 
min in 0.05% (v/v) Tween 20, 50 mM Tris saline buffer (TBS-T20)
for 1 h. The nuclear translocatio n of Nrf-2 was evaluated by immu- 
noﬂuorescence using an anti-Nrf-2 rabbit monoclonal antibody 
(1:200 dilution) (Santa Cruz) in TBS-T20 for 24 h at 4 C, followed 
by FITC conjugat ed antirabbit IgG secondary antibody (1:200 dilu- 
tion) (Vector) for 1 h. Cell nuclei were stained with Hoechst dye 
33,258 (5 lg/ml) for 15 min. The images were acquired from eight 
to ten randomly chosen ﬁelds using a ﬂuorescent microscope 
(Olympus BX41).
Statistical analysis 
All data were expresse d as mean ± SEM of at least three inde- 
pendent assays, each one in duplicate. Differences between groups 
were analyzed by one-way analysis of variance (ANOVA) followed 
by Tukey multiple range test when appropriate. Values of P < 0.05 
were considered statistically signiﬁcant.Fig. 1. (PhSe)2 prevents peroxynitrite-mediated apoptotic changes in endothelial 
cells, more efﬁciently than ebselen. Conﬂuent BAEC, maintained in a medium free of
serum, were pre-incubated with the indicated concentrations of (PhSe)2 or ebselen 
for 24 h. Then, cells were washed with PBS and treated with 500 lM peroxynitrite 
in PBS (1 ml/well) for 10 min. Subsequently, PBS was removed and replaced by fresh 
serum-free medium and incubated at 37 C for 6 h. Morphological apoptotic 
changes were assessed by nuclear morphology observation under a ﬂuorescent
microscope after nuclei staining with Hoechst 33,258, being considered apoptotic 
cells all those with condensed or fragmented nuclei. Results were expressed as the 
% of the total cell population. Control refers to the experiment in similar conditions 
without peroxynitrite and compounds. Data are mean ± S.E.M. from at least three 
independent experiments, each one assayed in duplicate. ###P < 0.001 vs. control;
⁄⁄P < 0.01 and ⁄⁄⁄P < 0.001 vs. peroxynitrite-treated cells.Results
Effect of diphenyl diselenide on cell viability 
In order to evaluate the potential beneﬁcial effects of (PhSe)2 on
peroxynitrite- mediated cell death, we started our experime nts by
assessing the appropriate non-toxic concentratio n of (PhSe)2 to
be used in the study. A 24 h dose-respon se study was conducted 
by exposing BAEC to increasing concentrations of (PhSe)2 ranging
from 0.5 to 8 lM. Cell viability was evaluated by the MTT assay.
As shown in Fig. 1 (Supplementary information ), there was no sig- 
niﬁcant decrease in cell viability over a 24 h exposure to (PhSe)2 at
concentratio ns below 2 lM. However, a decrease on cell viability 
at higher concentratio ns was observed with both ebselen and 
(PhSe)2. Ebselen was used in all the performed assays, as a refer- 
ence organoselenium compound . Based on these results, the max- 
imal nontoxic concentratio n of (PhSe)2 or ebselen used in the 
subsequent experiments was 1 lM.
Effect of diphenyl diselenide on peroxynit rite-mediated apoptotic 
changes
To investigate potential cytoprotecti ve effects of (PhSe)2 on the 
settings of peroxynitrite exposure, BAEC were pre-incubated with 
two different concentr ations, 0.5 and 1 lM, of either (PhSe)2 or
ebselen for 24 h and then exposed to 500 lM of bolus addition of
peroxynitrite, as described in ‘‘Materials and Methods’’. It should 
be highlighted that both compounds under study were not present 
in the incubation medium during or after cells treatment with per- 
oxynitrite. We have previousl y shown that BAEC exposed to high peroxyni trite concentrations (500 and 600 lM), for 6 h, exhibited 
apoptotic cell death [45]. Accordingly , after treatment with 
500 lM peroxynitrite, a high proportion of cells exhibited nuclear 
condensation, a hallmark of apoptosis (Fig. 1). In contrast, when 
cells were pre-treated with (PhSe)2, there was a decrease on apop- 
totic cells. As evidenced in the same ﬁgure, 0.5 lM (PhSe)2 inhib-
ited apoptosis by 63% whereas ebselen, at the same 
concentr ation, only prevented apoptotic cell death by about 30%.
However , although the maximal effect of (PhSe)2 was obtained at
this concentration, as 1 lM did not confer further protection, the 
anti-apopto tic effect of ebselen increased signiﬁcantly to 57% at
1 lM.
To conﬁrm the nature of cell death, we assessed the loss of plas- 
ma membran e integrity, a feature of necrosis, by measuring LDH 
release to the medium. As previously shown [45], LDH release from 
the cells exposed to peroxyni trite (500 lM) was not signiﬁcantly
different from the control cells. As expected, LDH release from 
BAEC pre-incubated with either (PhSe)2 or ebselen (0.5 and 
1 lM) for 24 h, and then exposed to peroxyni trite (500 lM) was 
not signiﬁcantly different from the control (data not shown),
stressing an apoptotic cell death pathway induced by
peroxyni trite.Diphenyl diselenide protects against protein tyrosine nitration 
Secondary oxidant species formed from proton mediated perox- 
ynitrite homolisis are able to promote nitration (incorporation of a
nitro –NO2 group) of aromatic and aliphatic amino acid residues.
Most notably, protein tyrosine residues constitute key targets for 
peroxyni trite-mediated nitration and the presence of 3-nitrotyro- 
sine in proteins represents a usual modiﬁcation introduced by
the biological formation of peroxynitrite [9]. Therefore we investi- 
gated the (PhSe)2 capacity to protect against this effect. BAEC were 
treated with (PhSe)2 or ebselen (1 lM) for 24 h, washed with PBS 
and subsequent ly exposed to three bolus of 50 lM peroxyni trite.
Fig. 2. (PhSe)2 and Ebselen diminishes protein nitration induced by peroxynitrite exposition in endothelial cells. (A) Bovine aortic endothelial cells were pre-incubated with 
1 lM of (PhSe)2 or Ebselen for 24 h. Subsequently, cells were washed with PBS and exposed to three bolus of 50 lM peroxynitrite in PBS. Western blot analysis was made as
described in Materials and Methods. (B) Densitometry analysis is expressed as relative fold increase of the 3-nitrotyrosine in respect to control (Ctl) condition. Values are 
mean ± S.E.M. of three experiments. ###P < 0,001 vs control; ⁄⁄⁄P < 0.001 vs ONOO .
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tein nitration promoted by peroxynitrite, proving that both orga- 
noselenium compounds can preserve the cell proteins from 
peroxynitrite damage.
Effect of diphenyl diselenide on glutathione synthesis 
Taking into account that GSH reacts with peroxyni trite, protect- 
ing cells from its oxidative and nitrating -mediated damage [50],
and that (PhSe)2 efﬁciently avoid peroxyni trite-triggered cell death 
(Fig. 1), we investigated the inﬂuence of (PhSe)2 on the cellular 
GSH biosynthesis. In this way, the GSH levels and the activity of
gamma-glu tamylcysteine synthetase (GGCS), a rate-limiting en- 
zyme of GSH biosynthesis , were evaluated.
As shown in Fig. 3A, a strong decrease in the intracellul ar GSH 
content were detected at the end of peroxynitrite treatment and 
pre-incubat ion of BAEC with (PhSe)2 did not prevent it. Of notice,
(PhSe)2 per se (0.5 and 1 lM), caused a signiﬁcant increase in the 
cellular GSH content. This cellular GSH increase , was accompanied 
by the augment in the GGCS activity after 3 and 6 h of (PhSe)2
treatment (Fig. 3C).
Fig. 3B and D show data from a parallel experiment with ebse- 
len, which under our assay conditions, neither prevented peroxyni- 
trite mediated GSH depletion nor increased the cellular GSH 
content and the GGSC activity.
Effect of diphenyl diselenide on cellular glutathio ne peroxidas e activity 
GSH and GPx are critically involved in cell protection against 
oxidative stress. GPx mediates the reduction of numerous reactive 
species, including peroxyni trite, at the expenses of GSH. In addi- 
tion, it is well documented the GPx-like activity of organoselenium 
compounds , such as ebselen and (PhSe)2 [34] .Therefor e, we inves- 
tigated the effect of (PhSe)2 on GPx enzyme activity in BAEC. As
shown in Fig. 4A, incubation of cells for 24 h with (PhSe)2 0.5
and 1 lM caused a signiﬁcant concentratio n-dependent increase 
on GPx activity of 2 and 2.5-fold, respectively. Treatment of cells 
with 1 lM ebselen produces a mild increase on GPx activity similar 
to that observed on cells pre-treated with 0.5 lM (PhSe)2 (Fig. 4A).
Additionally , we compared the GPx-like activities of (PhSe)2 and
ebselen by using an in vitro assay, as described in ‘‘Materials and 
Methods’’. Linear regression test demonst rated that (PhSe)2 pre-sented a signiﬁcant higher GPx-like activity than ebselen (slopes:
(PhSe)2 = 0.2618 ± 0.003867; ebselen = 0.1394 ± 0.005718;
P < 0.05), as evidenced in the Fig. 2 (Supplementary informat ion).
Effect of diphenyl diselenide on cellular glutathio ne peroxidase 
expression
The next step was to investigate the mechanis ms by which 
(PhSe)2 was able to impact GPx activity. As shown in Fig. 4B, incu- 
bation of BAEC with 0.5 and 1 lM (PhSe)2 for 24 h caused a signif- 
icant concentration- dependent increase in GPx expression. This 
increase was also evident in ebselen (1 lM) and Na2SeO3 (an inor- 
ganic form of selenium) treated cells. The Na2SeO3 was used as a
positive control taking into account its ability to serve as a sele- 
nium supplem ent to the medium which stimulates GPx synthesis 
[51].
Peroxynitri te does not react directly with diphenyl diselenide, but with 
its selenol derivative 
When peroxynitrite (20 lM) was rapidly mixed with (PhSe)2
(up to 10 lM) in sodium phosphat e buffer pH 7.4 and 37 C, no in- 
crease on peroxynitrite decompo sition rate was observed, indicat- 
ing that, under these experimental condition s, they did not react at
an appreciabl e rate (k2 < 104 M1 s1) (data not shown).
However , considering that reduction of (PhSe)2 to its selenol 
derivative, by reaction with thiols such as cysteine, dithiotreitol 
and reduced GSH, which has been considered relevant for its phar- 
macologi cal properties [52,53], we also investigated the reaction 
kinetics between peroxyni trite and selenoph enol. Incubation of
(PhSe)2 (8 lM) with excess of DTT (1 mM) in sodium phosphate 
buffer pH 7.4, at 37 C, caused a rapid (<1 min) and complete loss 
of the characteristic broad absorption band of diselenide, at around 
350 nm, indicating complete reduction of the compound by this 
high DTT excess (Fig. 5, inset).
When (PhSe)2 (0–4 lM) was incubate d with DTT (1 mM) for 
1 min before mixing with equal volumes of peroxynitrite (40 lM)
in diluted NaOH, peroxynitrite decomposed faster, and experime n-
tal traces still ﬁtted to exponential curves, indicating that selenol 
concentr ation was maintained constant during the time course of
the experime nt. The observed rate constant of peroxynitrite 
decompo sition, in the presence of DTT (500 lM) alone, was 
Fig. 3. (A) Effect of (PhSe)2 on GSH biosynthesis. (A and B) Bovine aortic endothelial cells were pre-incubated with the indicated concentrations of (PhSe)2 or ebselen for 24 h.
Subsequently, cells were washed with PBS and some of them were treated with 500 lM peroxynitrite in PBS (1 ml/well) for 10 min. GSH was quantiﬁed immediately at the 
end of the peroxynitrite addition, as described in Materials and Methods. (C and D) Cells were pre-incubated with 1 lM of (PhSe)2 or ebselen for 3, 6 and 24 h. Subsequently,
cells were washed with PBS and the gamma-glutamylcysteine synthetase (GGCS) activity was measured, as described in Materials and Methods and expressed as nmol NADH 
consumed per minute per mg of protein. Control refers to incubated BAEC alone. Values are mean ± S.E.M. of ﬁve experiments, each one in duplicate. ⁄P < 0.1; ⁄⁄P < 0.01;
⁄⁄⁄P < 0.001 vs control.
A.F. de Bem et al. / Nitric Oxide 31 (2013) 20–30 251.7 s1, at pH 7.4 and 37 C, consistent with a slow reaction be- 
tween peroxynitrite and this dithiol-contai ning compound. How- 
ever, this constant increased linearly with increasing 
concentratio ns of selenophenol (0–8 lM), allowing us to deter- 
mine a second order rate constant for peroxynitrite- mediated sel- 
enophenol oxidation of 2.7  105 M1 s1 at pH 7.4 and 37 C
(Fig. 5).Effect of diphenyl diselenide on the translocation of the transcription 
factor Nrf-2 
It has been proposed that phase 2 inducers disrupt the Keap1- 
Nrf-2 complex by modifying the cysteine residues of Keap1 [54],
allowing Nrf-2 to transloca te to the nucleus where, in heterodi- 
meric combinations with other basic leucine zipper proteins, it
binds to the ARE of the phase 2 genes and accelerates their tran- 
scription. Ebselen is known to promote the nuclear translocatio n
of the transcription factor Nrf-2 by oxidation of a cysteine residue 
in Keap1. Since (PhSe)2 is able to enhance GPx expression and GSH 
content, we investigated if the (PhSe)2 could exert its protective 
mechanism against peroxynitrite via stimulation of Nrf-2 translo- 
cation to the nucleus. BAEC were treated with 1 lM (PhSe)2 or
ebselen for 3 and 24 h and immunocytochem istry was performed 
as described in ‘‘Materials and Methods’’. According to Fig. 6
(PhSe)2 promote d the Nrf-2 nuclear translocation in 3 h, whereas 
ebselen in 24 h. This earlier nuclear Nrf-2 translocation augments 
the cell defenses promptly protectin g from the oxidative injury.Discussion
Peroxynitrit e is a highly reactive species, inducing a stress re- 
sponse in cells. If the damage caused by peroxynitrite exceeds 
the capacity of a target cell to restore a normal state, stress-respon- 
sive mechanism s may lead to apoptosis [55–57]. Although cellular 
effects of ebselen and its protectiv e effect against peroxyni trite-in- 
duced damage have been already reported [50,58,59], no informa- 
tion concerning (PhSe)2 effects against such damage is yet 
available . Therefore, in the present study, we examined the protec- 
tion afforded by (PhSe)2 against the damage induced by authentic 
peroxyni trite in BAEC, in comparison with ebselen.
Recently , it has been reported that ebselen possesse s a potent 
inhibitory activity against either oxysterol-induced cytotoxicity 
[60], TNF- a-induced JNK activation, or adhesion molecule expres- 
sion [61] in endotheli al cells; its protective effect against H2O2-in-
duced death in human umbilical vein endothelial cells has also 
been shown [62]. These results point to the potential usefulness 
of ebselen in preventing and/or treating endotheli al cell dysfunc- 
tion, which plays a key role in initiating the atherogenesis process.
However , no evidence has been yet provided concerning the effect 
of (PhSe)2 on endothelial cell dysfunction . Importantly, (PhSe)2 dis-
plays a lower toxicity than ebselen [36,63,64]. In addition, ebselen 
is a more complex molecule, its synthesis being more expensive 
and time-consuming, as compared with that of diselenides [53].
The results presente d here demonstrat e, for the ﬁrst time, that 
pre-treatment of BAEC with low micromolar concentrations of
(PhSe)2 signiﬁcantly protected them from peroxynitrite-p romoted 
Fig. 4. Effect of (PhSe)2 on cellular GPx activity and expression, as compared with 
ebselen. (A) Bovine aortic endothelial cells were pre-incubated with the indicated 
concentrations of (PhSe)2 or ebselen for 24 h. Cellular GPx activity was measured as
described in Materials and Methods and expressed as nmol NADPH consumed per 
mg of protein. Values are mean ± S.E.M. from at least three independent exper- 
iments, each one assayed in duplicate. (B) same experimental design as in A, but the 
cells were pre-incubated also with a positive control, sodium selenite (Na2SeO3)
40nM. Cellular GPx expression was determinate as described in Materials and 
Methods and expressed as GPx4 densitometry per b-actin densitometry. 1-control;
2-Na 2SeO3; 3-(PhSe)2 0.5 lM; 4-(PhSe)2 1.0 lM; 5-ebselen 0.5 lM; 6-ebselen 1 lM.
Values are mean ± S.E.M. from at least three independent experiments. ⁄P < 0.05;
⁄⁄⁄P < 0.001 vs control.
Fig. 5. Increasing (PhSe)2 concentrations were reduced by incubation with DTT 
(1 mM) during 1 min, and then rapidly mixed with peroxynitrite (20 lM, ﬁnal
concentration) in 50 mM PBS, 0.1 mM DTPA, pH 7.4 and 37 C. Experimental traces 
were ﬁtted to exponential decays, and observed rate constants of peroxynitrite 
decay in the presence of DTT and different concentrations of reduced compound 
were plotted against its concentration. From the slope of this plot, a second order 
rate constant of 2.7  105 M1 s1, at pH 7.4 and 37 C, for the reaction between 
peroxynitrite and selenophenol was determined. Inset: absorbance spectra of
(PhSe)2 (continuous line) and (PhSe)2 incubated with 1 mM DTT for 1 min (dashed
line) in 50 mM PBS, 0.1 mM DTPA pH 7.4 and 37 C.
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by some of us [45], an apoptotic, non-necrotic, pathway for perox- 
ynitrite-induce d cell death was observed, triggering condensation 
and fragmentation of the nucleus, without LDH leakage to the extra- 
cellular medium. This cell death pathway was drastically inhibited 
by pre-incubat ion of BAEC with 0.5 and 1.0 lM (PhSe)2, in a more 
efﬁcient way than similar treatment with ebselen at same concen- 
trations. Additionally , the pre-treatment with (PhSe)2 and ebselen 
for 24 h protected against tyrosine nitration promote d by peroxyni- 
trite, evidence that these organoselenium compounds are able to
protect cells against peroxynitrite-m ediated damage. In this way,
we recently demonstrated that (PhSe)2 efﬁciently reduced athero- 
sclerotic lesions in hypercholester olemic LDLr / mice by decreas- 
ing nitrotyrosin e and malondialde hyde levels in aortic tissue [40].
As mentioned before, the antioxidant propertie s of organosele- 
nium compounds have attracted much attention, particularly, due 
to its potential GPx-like activity via formation of selenol interme- 
diates. The GPx system represents one the major lines of defense 
against not only hydrogen peroxide and lipid hydroperoxides , but 
also against peroxynitrite [58,65], reducing these reactive species 
via oxidation of the selenol group. In fact, it has been demonstrated 
that this enzymatic system possesses the ability to act also as per- 
oxynitrite reductase, preventin g both oxidation and nitration reac- 
tions caused by peroxynitrite [66]. Therefore, the reaction of GPx 
with peroxynitrite has been considered a biologica lly efﬁcientdetoxicat ion pathway in vivo [19]. Considering that GPx and related 
enzymes are important cellular tools to detoxify oxidants, such as
peroxyni trite, possible underlyin g protective mechanism s, via up- 
regulatio n of the intracellular GSH level and increase in GPx activity,
were explored and are supported by the results shown herein.
Both ebselen and (PhSe)2 have revealed strong antioxidant 
propertie s that may result from their GPx-like activities 
[53,58,59 ]. Accordingly , our data also indicate that GPx-like activ- 
ity of (PhSe)2, as directly measured in vitro , is much higher than 
that of ebselen (Fig. 2 Supplement ary information), in agreement 
with the study of Wilson et al. [34]. Moreover, pre-incubat ion of
BAEC with 0.5 and 1.0 lM (PhSe)2 signiﬁcantly increased cellular 
GPx activity (Fig. 4A), an effect that can be attributed to its direct 
action on the cells, since it was removed from the medium before 
measuring the GPx activity. Such increase in GPx activity may be
suggested as a plausible mechanism underlying the protective role 
of (PhSe)2 against peroxynitrite- induced cell death and responsib le
for the higher protection afforded by this compound as compared 
with ebselen. In fact, in contrast with (PhSe)2, ebselen caused less 
improvem ent in cellular GPx activity. (Fig. 4A). Although the GPx 
activity of organoseleni um compounds can be catalytica lly main- 
tained with physiologica lly relevant concentrations of thiol reduc- 
tants (e.g., GSH), this process is not as efﬁcient as the native GPx 
enzymes [34,67]. Therefore, an indirect effect seems to be involved 
in the protective effect of (PhSe)2 against peroxynitrite. In this way,
the increase in cellular peroxidase activity was accompanied by an
increase in GPx protein expression when cells were exposed to
both organosel enium compounds (Fig 4B). These results suggest 
that besides its direct effect as a mimetic of GPx, (PhSe)2 could
act indirectly by activating gene expression related with the cell’s 
redox enzyme system.
GSH is the main non-protein thiol involved in the antioxidant 
defense and is the major contributor to the cellular redox state 
[68]. It is ubiquitousl y present in cells at millimola r concentratio ns
(5–10 mM). Although the rate constant of peroxynitrite with GSH 
is not very high (k2 = 1.3  103 M1 s1, pH 7.4, 37 C) [5], its high 
intracellul ar concentratio n and its capacity to react with peroxyni -
trite-derive d radicals, turns this thiol into a potent endogen ous 
scavenge r of peroxynitrite [50]. In fact, peroxynitrite-m ediated 
oxidations increase at cellular level, when cells are depleted of
GSH, and high levels of GSH afford protection against drug toxicity,
in which peroxyni trite seems to be involved [69]. Accordingly and 
Fig. 6. Effect of (PhSe)2 on Nrf-2 translocation, as compared with ebselen. BAEC were pre-incubated with 1 lM of (PhSe)2 and ebselen for 3 and 24 h. Imunoﬂuorescence was 
assessed by Nrf-2 signal as described in Material and Methods. Shown are immunoreactivity for Nrf-2 (red), nuclear staining with Hoechst 33,258 (blue), and merged images 
of each of the two treatments. Cultures treated with (PhSe)2 presented an earlier Nrf-2 translocation as compared with ebselen. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this book.)
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vel was observed in BAEC after peroxyni trite exposure. Pre-incuba- 
tion of cells with either (PhSe)2 or ebselen did not prevent 
peroxynitrite- promoted GSH depletion. However, (PhSe)2 per se, in
the absence of peroxyni trite, stimulated a signiﬁcant increase in
the intracellular GSH pool (Fig. 3A), in contrast with ebselen, which 
causes only a slight, non-signiﬁcant, increase in GSH level (Fig. 3B).
Such increase in cellular GSH may be due to an increase in GSH bio- 
synthesis after (PhSe)2 treatment, similarly to that described for 
other compound s [45]. Therefore, the decrease in intracellular GSH 
level after treatment with peroxynitrite, also observed in the pres- 
ence of organoselenium compounds, could be explained by the fact 
that the GPx system, plus GSH, works catalytically , in order to reduce 
peroxynitrite to nitrite, at the expense of GSH [66]. Thus, our data 
suggest that (PhSe)2 may have a key role in peroxynitrite detoxiﬁca-
tion in BAEC, either directly by signiﬁcantly increasing the cellular 
levels of GSH, which is a peroxyni trite scavenger and a substrate of
GPx, or indirectly by improving the cellular GPx activity.
One of the cellular responses to stress involves signaling 
through antioxidant or electrophile response elements , mediated by the transcriptio n factor Nrf-2. A feature of Nrf-2-depen dent 
inducers is that they increase the level of intracellular GSH, even 
though they may initially cause GSH depletion. In our study, the 
signiﬁcant increase in GSH level could be related to the earlier 
(PhSe)2-induced increase in GGCS activity (Fig. 3C). The expression 
of a diverse array of enzymes involved with the amelioration of
oxidative stress, including GGCS and GPx, has been shown to be in- 
duced by Nrf-2-depen dent mechanism s [70]. In this way, previous 
studies showed the effect of ebselen in activating Nrf-2-depen dent 
responses [29–31], and here, for the ﬁrst time, we demonstrat ed
that (PhSe)2 promote s an early and effective Nrf-2 nuclear translo- 
cation (Fig. 6). The result of this process seems to be the mecha- 
nism responsible for the intracellul ar increase in GSH levels and 
GPx expression (Scheme 1).
Keap1, a repressor of the Nrf-2 transactivati on activity, is
known to play a central role in regulatin g the adaptive responses 
to electrophilic and oxidative stresses. The high cysteine content 
of Keap1 suggests that it could be an excellent candidate as the 
sensor for inducers. It has been suggested that these cysteine res- 
idues constitute a multicompone nt redox-se nsitive switch that 
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Scheme 1. Proposed mechanism of protective effect of (PhSe)2 against peroxinytrite toxicity. (PhSe)2 can activate Nrf2 signaling through oxidation of Keap1 cysteine thiols,
which leads to a net transfer of Nrf2 to the nucleus and increases the transcription of a range of genes involved in defence against oxidative/nitrosative stress and cellular 
survival. Moreover, the interaction of (PhSe)2 with thiol equivalentes generated a selenol, which can react and consequently neutralize peroxinytrite.
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scription. Our observati ons that (PhSe)2 induced a redox regulatio n
and nuclear localization of Nrf-2, as already demonstrat ed by ebse- 
len [30], suggest that this organoseleni um compound could di- 
rectly interact with the sensor protein Keap1.
In addition, our data on reaction kinetics indicated that (PhSe)2
was not able to react directly with peroxyni trite, and the second- 
order rate constant of peroxynitrite and selenophenol , a selenol 
intermediate formed by reduction of (PhSe)2, was also lower than 
that reported by ebselen [20] (Fig. 5). This also suggests that the re- 
ferred protectiv e effect displayed by (PhSe)2 against peroxynitrite- 
mediated cell death is not due to a direct reaction with peroxyni- 
trite, unless very high intracellul ar concentratio n of the compound 
(>100 lM) could be achieved 2 at least in speciﬁc cellular 
compartmen ts.2 With a second order rate constant of 2.7  105 M1 s1 for its reaction with 
peroxynitrite, and a reduced phenyl selenol concentration lower than 100 lM, the 
product rate constant times concentration would be of 27 s1. Other potential 
intracellular targets of peroxynitrite reactivity include GSH and CO2. In both cases,
rat e con stant s wit h pero xyni tri te are lowe r tha n wit h this sel eno l-c ont aini ng
compound but taking into account their high concentrations in cells, products of
rat e con stant tim es conc entration are around 10 s1 and 56 s1, res pectiv ely,
indicating that at phenyl selenol concentrations lower than 100 lM, CO2 instead of
phenyl selenol would be a preferential target for peroxynitrite reactivit y. The 
reactivity of selenol-containing compounds with carbonate and nitrogen dioxide 
radicals, formed from peroxynitrite in the presence of CO2, has not been addressed to
date.In conclusion, (PhSe)2, like ebselen, shows a signiﬁcant protec- 
tive effect against peroxyni trite-mediated endothelial cell death.
To our knowled ge, this study is the ﬁrst to show that such protec- 
tion may be mediated by Nrf-2-de pendent mechanis ms, resulting 
in an increase in both intracellular GSH and GPx levels, which 
may lead to reduction of peroxyni trite to nitrite at the expense 
of GSH. Of note, these ﬁndings may shed new light on the pharma- 
cological basis for the clinical applicati ons of (PhSe)2 as a potential 
antiatheros clerotic compound.
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